Validation of the optimal scaffold pore size of nasal implants using the 3-dimensional culture technique
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Nam, Jeoung Hyun | - |
dc.contributor.author | Lee, So Yun | - |
dc.contributor.author | Khan, Galina | - |
dc.contributor.author | Park, Eun Soo | - |
dc.date.accessioned | 2021-08-11T08:34:19Z | - |
dc.date.available | 2021-08-11T08:34:19Z | - |
dc.date.issued | 2020-07 | - |
dc.identifier.issn | 2234-6163 | - |
dc.identifier.issn | 2234-6171 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/2670 | - |
dc.description.abstract | Background To produce patient-specific nasal implants, it is necessary to harvest and grow autologous cartilage. It is crucial to the proliferation and growth of these cells for scaffolds similar to the extracellular matrix to be prepared. The pore size of the scaffold is critical to cell growth and interaction. Thus, the goal of this study was to determine the optimal pore size for the growth of chondrocytes and fibroblasts. Methods Porous disc-shaped scaffolds with 100-, 200-, 300-, and 400-mu m pores were produced using polycaprolactone (PCL). Chondrocytes and fibroblasts were cultured after seeding the scaffolds with these cells, and morphologic evaluation was performed on days 2, 14, 28, and 56 after cell seeding. On each of those days, the number of viable cells was evaluated quantitatively using an MTT assay. Results The number of cells had moderately increased by day 28. This increase was noteworthy for the 300- and 400-mu m pore sizes for fibroblasts; otherwise, no remarkable difference was observed at any size except the 100-mu m pore size for chondrocytes. By day 56, the number of cells was observed to increase with pore size, and the number of chondrocytes had markedly increased at the 400-mu m pore size. The findings of the morphologic evaluation were consistent with those of the quantitative evaluation. Conclusions Experiments using disc-type PCL scaffolds showed (via both morphologic and quantitative analysis) that chondrocytes and fibroblasts proliferated most extensively at the 400-mu m pore size in 56 days of culture. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한성형외과학회 | - |
dc.title | Validation of the optimal scaffold pore size of nasal implants using the 3-dimensional culture technique | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.5999/aps.2020.00213 | - |
dc.identifier.scopusid | 2-s2.0-85088610336 | - |
dc.identifier.wosid | 000551940300006 | - |
dc.identifier.bibliographicCitation | Archives of Plastic Surgery, v.47, no.4, pp 310 - 316 | - |
dc.citation.title | Archives of Plastic Surgery | - |
dc.citation.volume | 47 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 310 | - |
dc.citation.endPage | 316 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002609465 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | esci | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.subject.keywordPlus | PCL SCAFFOLDS | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | CELLS | - |
dc.subject.keywordAuthor | Porosity | - |
dc.subject.keywordAuthor | Rhinoplasty | - |
dc.subject.keywordAuthor | Artificial implant | - |
dc.subject.keywordAuthor | Chondrocyte | - |
dc.subject.keywordAuthor | Fibroblast | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.